Royal Surrey County Hospital

EQS-News: International Experts Highlight Demand for Diagnostic Innovations as PenKid's Research and Real-World Data Fuels Quest for Improved RRT Liberation Tools

Retrieved on: 
Wednesday, September 6, 2023
Royal Surrey County Hospital, Hospice and palliative medicine, University, Consultant, E pluribus unum, RRT, Critical Care (journal), Overalls, Renal replacement therapy, Biomarker, AKI, Intensive care medicine, Acute kidney injury, CRRT, Professor, University Hospital Heidelberg, Patient, School, RICH, Mortality, University of Surrey, Intensive care unit, Health, Southern Illinois University School of Medicine, Pharmaceutical industry, Medical imaging, Nursing

Recently published scientific data affirms that penKid remains informative under acute renal replacement therapy (RRT) and can identify patients for successful liberation.

Key Points: 
  • Recently published scientific data affirms that penKid remains informative under acute renal replacement therapy (RRT) and can identify patients for successful liberation.
  • RRT, a common practice in Intensive Care Units (ICUs), has long relied on clinical observations for stop decisions.
  • However, the lack of a dependable biomarker poses challenges in accurately assessing when to discontinue RRT.
  • Considering this, leading experts from the field have discussed in a recent advisory board the importance of identifying the right tools to improve the outcomes in AKI.

Sight Sciences OMNI® Surgical System to Be Featured in Multiple Presentations at the 2022 European Society of Cataract and Refractive Surgery Annual Meeting

Retrieved on: 
Friday, September 16, 2022
Omni, Adult, Glaucoma, FEBO, OMNI, Compliance, Physician, Cataract, Eye, Adoption, Multicenter Automatic Defibrillator Implantation Trial, Consultant, MBA, Doctor of Philosophy, Surgeon, OAG, Systematic, FDA, Duane syndrome, European Society of Neurogastroenterology and Motility, Health, Catheter, MIGS, Princess Alexandra Eye Pavilion, CEO, Interim, Severe cognitive impairment, GLOBE, Intraocular pressure, MGD, IOP, Trauma, Royal College of Ophthalmologists, Systematic review, Trabecular meshwork, Use, Moderate, Exocrine gland, Royal Surrey County Hospital, Medical device, Surveying, Flour, Dentistry, MD, Patient

MENLO PARK, Calif., Sept. 16, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. announced today that its OMNI Surgical System will be featured in seven clinical presentations at the 2022European Society of Cataract & Refractive Surgeons(ESCRS) meeting, to be held inMilan, ItalyonFriday, September 16throughTuesday, September 20.

Key Points: 
  • MENLO PARK, Calif., Sept. 16, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. announced today that its OMNI Surgical System will be featured in seven clinical presentations at the 2022European Society of Cataract & Refractive Surgeons(ESCRS) meeting, to be held inMilan, ItalyonFriday, September 16throughTuesday, September 20.
  • He continued, We are honored to witness the growing adoption of the OMNI Surgical System in both combination cataract procedures as well as in standalone use.
  • Sight Sciences is an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients lives.
  • The OMNI Surgical System is a handheld, single-use therapeutic device for minimally invasive glaucoma surgery (MIGS).